SCHEMBL21687754

SCHEMBL21687754

N#Cc1ccc([Si](c2ccccc2)(c2ccccc2)c2ccccc2)c(-c2cccc(C#N)c2-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
TSHR P16473 1/20 0.32
TDP2 O95551 1/20 0.31
CYP19A1 P11511 1/20 0.31
MAPT P10636 2/20 0.31
HTT P42858 2/20 0.31
PTGER4 P35408 1/20 0.31
KDM4E B2RXH2 2/20 0.30
GLA P06280 1/20 0.30
GAA P10253 1/20 0.30
HSD17B10 Q99714 1/20 0.30
METAP2 P50579 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687540 0.97 PTGER4 (0.31) ALDH1A1SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL21687903 0.91 ALDH1A1 (0.32) ALDH1A1SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL21687553 0.91 TDP2 (0.31) ALDH1A1TDP2PTGER4KDM4EGLA
SCHEMBL21687618 0.88 SMN1; SMN2 (0.35) ALDH1A1SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL21687811 0.88 PTGER4 (0.31) ALDH1A1TDP2PTGER4KDM4EGLA
SCHEMBL21688015 0.88 KDM4E (0.33) ALDH1A1TDP2KDM4EGLAGAA
SCHEMBL21687489 0.86 PTGER4 (0.30) ALDH1A1SMN1; SMN2PTGER4KDM4EGLA
SCHEMBL21687695 0.86 PTGER4 (0.32) PTGER4
SCHEMBL21688142 0.85 PTGER4 (0.32) ALDH1A1TDP2PTGER4KDM4EGLA
SCHEMBL21687612 0.84 ALDH1A1 (0.34) ALDH1A1TDP2CYP19A1PTGER4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 ALDH1A1 616/4885SMN1; SMN2 4039/4885MEN1 669/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 ALDH1A1 616/4885SMN1; SMN2 4039/4885MEN1 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.